The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
APOL1-Associated Nephropathy: A Key Contributor to Racial Disparities in CKD
Open accessAbstract
Genetic methodologies are improving our understanding of the pathophysiology in diverse diseases. Breakthroughs have been particularly impressive in nephrology, where marked disparities exist in rates and etiologic classifications of ESKD between African Americans and European Americans. Discovery of the apolipoprotein L1 gene (APOL1) association with focal segmental glomerulosclerosis, HIV-associated nephropathy, lupus nephritis, sickle cell nephropathy, and solidified glomerulosclerosis, as well as more rapid failure of transplanted kidneys from donors with APOL1 renal-risk genotypes has improved our understanding of non-diabetic nephropathy. Environmental factors acting via natural selection in sub-Saharan African populations likely underlie this association. This article describes the discovery of chromosome 22q renal-risk variants and their worldwide distribution, reviews the epidemiology and pathology of APOL1- associated nephropathies, and explores several proposed mechanisms of renal injury identified in cell culture and animal models. Detection of the APOL1 associations with kidney diseases and delineation of injury pathways brings hope for effective treatment for these kidney diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325
Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
Genovese, G., Friedman, D. J., Ross, M. D., Lecordier, L., Uzureau, P., Freedman, B. I., Bowden, D. W., Langefeld, C. D., Oleksyk, T. K., Uscinski Knob, A. L., et al. (2010) · Science · doi:10.1126/science.1193032 · Cited by 2,028
Self-citationEffect of Replacing Race With Apolipoprotein L1 Genotype in Calculation of Kidney Donor Risk Index
Julian, B. A., Gaston, R. S., Brown, W. M., Reeves-Daniel, A. M., Israni, A. K., Schladt, D. P., Pastan, S. O., Mohan, S., Freedman, B. I., & Divers, J. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14113 · Cited by 69
Self-citation
Cited by
The Missing Diversity in Human Genetic Studies
Sirugo, G., Williams, S. M., & Tishkoff, S. A. (2019) · Cell · doi:10.1016/j.cell.2019.02.048 · Cited by 1,516
Signaling pathways of chronic kidney diseases, implications for therapeutics
Yuan, Q., Tang, B., & Zhang, C. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01036-5 · Cited by 453
Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities
Opazo-Ríos, L., Mas, S., Marín-Royo, G., Mezzano, S., Gómez-Guerrero, C., Moreno, J. A., & Egido, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072632 · Cited by 363
Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease
Mitrofanova, A., Merscher, S., & Fornoni, A. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00741-w · Cited by 356
Ahmed, S., Nutt, C. T., Eneanya, N. D., Reese, P. P., Sivashanker, K., Morse, M., Sequist, T., & Mendu, M. L. (2021) · Journal of General Internal Medicine · doi:10.1007/s11606-020-06280-5 · Cited by 147
Metadata
- Authors
- Freedman, B. I., Limou, S., Ma, L., & Kopp, J. B.
- Venue
- American Journal of Kidney Diseases
- Publisher
- Elsevier BV
- Published
- 2018-11
- Volume
- 72
- Issue
- 5
- Pages
- S8-S16
- ISSN
- 0272-6386 (ISSN-L)
- OpenAlex
- W2896700085
- Cited by
- 162
- References
- 3
- FWCI
- 13.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: APOL1-Associated Nephropathy: A Key Contributor to Racial Disparities in CKD. https://app.cochat.ai/papers/10.1053/j.ajkd.2018.06.020
- The paper
- Freedman, B. I., Limou, S., Ma, L., & Kopp, J. B. (2018). APOL1-Associated Nephropathy: A Key Contributor to Racial Disparities in CKD. American Journal of Kidney Diseases. https://doi.org/10.1053/j.ajkd.2018.06.020
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.